Suppr超能文献

镁在心血管系统病理生理学中作用的新视角。II. 实验方面。

New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. II. Experimental aspects.

作者信息

Altura B M, Altura B T

出版信息

Magnesium. 1985;4(5-6):245-71.

PMID:3914581
Abstract

It has generally been believed that the physiological roles for magnesium ions (Mg2+) in cardiac and vascular smooth muscle are limited to regulation of contractile proteins, sarcoplasmic reticular membrane transport of calcium ions (Ca2+), cofactor in ATPase activities and metabolic regulation of energy-dependent cytoplasmic and mitochondrial pathways. In addition, up until recently, it was not thought that small changes in free external ([Mg2+]0) or cytoplasmic Mg2+ could exert any significant effects on cardiac or vascular smooth muscle contractility. It is clear, however, from the newer studies that [Mg2+]0 can affect tension and contractility of these muscle cells by altering membrane and intracellular organelle binding and transport of Ca2+, affecting hormone-receptor interactions, regulating electrolyte content and transport, affecting resting membrane-generated and action potentials, altering excitation-contraction coupling events, and regulate peripheral and cerebral vascular tone and blood flow. In addition, it is also now clear that small changes of free [Mg2+] at the cardiac and vascular muscle membranes can exert significant effects on mechanical and electrical activities of these cells. Considerable new data lend support to the idea that [Mg2+]0 is fundamental in the regulation of cardiovascular homeostasis. Dietary, metabolic or drug-induced changes in Mg2+ levels appear to play important roles in the etiology of cardiac and vascular disorders. Evidence is reviewed and presented to indicate that Mg2+ is important in the pathophysiology and treatment of certain forms of experimental and genetic types of hypertension. This divalent cation may also be important in the etiology of a variety of disorders which have vasospasm in common. Evidence is reviewed to support the concept that Mg2+ is a naturally occurring or mimic weak Ca2+ antagonist, which should be useful in the treatment of several types of cardiac and vascular disorders.

摘要

人们普遍认为,镁离子(Mg2+)在心脏和血管平滑肌中的生理作用仅限于调节收缩蛋白、肌浆网对钙离子(Ca2+)的膜转运、ATP酶活性的辅助因子以及能量依赖的细胞质和线粒体途径的代谢调节。此外,直到最近,人们还认为细胞外游离镁离子([Mg2+]0)或细胞质镁离子的微小变化不会对心脏或血管平滑肌的收缩性产生任何显著影响。然而,从最新的研究中可以清楚地看出,[Mg2+]0可以通过改变膜和细胞内细胞器对Ca2+的结合和转运、影响激素-受体相互作用、调节电解质含量和转运、影响静息膜电位和动作电位、改变兴奋-收缩偶联事件以及调节外周和脑血管张力及血流量,来影响这些肌肉细胞的张力和收缩性。此外,现在也清楚地知道,心脏和血管肌膜处游离[Mg2+]的微小变化会对这些细胞的机械和电活动产生显著影响。大量新数据支持了[Mg2+]0在心血管稳态调节中至关重要这一观点。饮食、代谢或药物诱导的镁离子水平变化似乎在心脏和血管疾病的病因中起重要作用。本文回顾并呈现了相关证据,表明镁离子在某些形式的实验性和遗传性高血压的病理生理学及治疗中很重要。这种二价阳离子在多种具有共同血管痉挛特征的疾病病因中可能也很重要。本文回顾了相关证据以支持镁离子是一种天然存在的或模拟的弱Ca2+拮抗剂这一概念,这在治疗多种类型的心脏和血管疾病中应该是有用的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验